VOR

Vor Biopharma Inc

NASDAQ: VOR · HEALTHCARE · BIOTECHNOLOGY

$17.25

-8.10% today

Updated 2026-06-05

Market cap

$763.48M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-70.40

Dividend yield

—

52W range

$4 – $66

Volume

1.0M

Market cap

$763.48M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-70.40

Dividend yield

—

52W range

$4 – $66

Volume

1.0M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

6.5

Quality

3.0

Profitability

5.0

Valuation

C+

2/9

Piotroski F-Score

Weak

-5.0

Altman Z-Score

Distress

—

Industry rank

—

View all highly rated stocks (75+) →202 stocks currently score above 75

Price targets

Analyst target

$37.88

+119.59%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

1 Strong Buy7 Buy1 Hold0 Sell0 Strong Sell

Price chart

Stock snapshot

Strengths

+ Debt/equity -0.02x — low leverage

Risks

- Piotroski 2/9 — weak financial health

- Altman Z -5.00 — distress zone

- Thin margins at 0.00%

- Negative free cash flow $-38.29M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-92.09M	$-117.86M	$-116.91M	$-695.98M	$-219.59M
EPS	—	—	—	—	$-70.40
Free cash flow	$-93.61M	$-101.36M	$-99.89M	$-143.65M	$-38.29M
Profit margin	—	—	—	—	—

Recent insider activity

Date	Insider	Type	Shares	Price
2026-04-22	RA, CAPITAL MANAGEMENT, L.P.	Sale	165,150	$15.77
2026-04-20	RA, CAPITAL MANAGEMENT, L.P.	Sale	171,963	$15.77
2026-04-17	RA, CAPITAL MANAGEMENT, L.P.	Sale	458,411	$16.28

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
VOR	$763.48M	32	4.3	3.0	5.0	6.5	—	Avoid
LLY	$948.95B	78	10.0	10.0	5.0	6.0	—	Strong Buy
JNJ	$536.54B	59	4.7	9.0	3.3	6.0	-71.41%	Buy
ABBV	$380.57B	63	4.0	8.0	4.0	5.0	-55.64%	Buy
UNH	$343.21B	54	5.3	5.5	4.7	5.5	-26.61%	Buy
MRK	$285.64B	50	3.3	8.0	2.7	5.0	-49.34%	Hold

Smart narrative

Vor Biopharma Inc trades at $17.25. Our Smart Value Score of 32/100 indicates the stock is weak. The company scores 2/9 on the Piotroski F-Score. With an Altman Z-Score of -5.00, it sits in the distress.

Frequently asked questions

What is Vor Biopharma Inc's stock price?

Vor Biopharma Inc (VOR) trades at $17.25.

Is Vor Biopharma Inc overvalued?

Vor Biopharma Inc carries a Smart Value Score of 32/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.

What is the price target of Vor Biopharma Inc (VOR)?

The 12-month analyst consensus target is $37.88, about 119.6% above the current $17.25. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.

Altman Z-Score?

Vor Biopharma Inc's Altman Z-Score is -5.00, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio—

ROE-125.40%

Beta1.73

50D MA$15.08

200D MA$18.57

Shares out0.05B

Float0.04B

Short ratio—

Avg volume1.0M

Performance

1 week+0.00%

1 month-10.05%

3 months-4.36%

YTD+0.61%

1 year—

3 years—

5 years—

Compare

VOR vs LLY →VOR vs JNJ →VOR vs ABBV →Stock screener →